THERE is a growing need to raise awareness about the effectiveness of generic drugs amid the increasing cost of healthcare. A 2022 survey by the UCSI Poll Research Centre survey involving 1,060 ...

This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S. Keeping up its string of pilots in recent months, the FDA on Friday unwrapped a ...

The settlement agreement will extend market exclusivity for AbbVie’s JAK inhibitor in the U.S. until 2037—providing pediatric exclusivity is granted. AbbVie has reached a settlement with generic ...

A new analysis from GoodRx explores how 2025 is shaping up for Food and Drug Administration drug approvals, and the early data tells a mixed story. Importantly, a growing disconnect remains between ...

Generic brands, sometimes referred to as "private label" or "store brands," are increasingly popular today as shoppers face rising food prices in grocery stores. Some consumers believe these brands to ...

A revolution is coming in the U.S. generics marketplace, one that players in the space ignore at their peril. This revolution has the potential to transform savvy organizations into engines of growth, ...

Prescription drug prices in the United States remain a major financial burden for millions of Americans. As healthcare costs rise and insurance coverage becomes increasingly complex, patients are ...

The month of September is known as the Generics Awareness Month. The event celebrates the passing of the law – the Generics Act of 1988 or Republic Act No. 6675 which guarantees all Filipinos ...